COAG · Hemab Therapeutics Holdings, Inc. · Fails to Deliver
$38.56
-0.59 (-1.51%)
At close · Nov 19
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$1.83B
Shares
46.73M
Volume · Nov 19
59.54K
Avg daily vol (3M)
496.12K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-10-29 | 102,646 | $38.50 | $3,951,871 |
| 2026-10-28 | 243 | $38.40 | $9,331 |
| 2026-10-27 | 7,835 | $36.02 | $282,217 |
| 2026-10-23 | 999 | $34.82 | $34,785 |
| 2026-10-22 | 1,021 | $35.34 | $36,082 |
| 2026-10-21 | 169 | $34.17 | $5,775 |
| 2026-10-20 | 1,140 | $32.09 | $36,583 |
| 2026-10-19 | 860 | $30.07 | $25,860 |
| 2026-10-16 | 32,370 | $32.52 | $1,052,672 |
| 2026-10-15 | 507 | $29.94 | $15,180 |
| 2026-10-14 | 1,685 | $29.80 | $50,213 |
| 2026-10-08 | 214 | $28.70 | $6,142 |
| 2026-10-07 | 10,910 | $28.37 | $309,517 |
| 2026-09-30 | 15,392 | $32.60 | $501,779 |
| 2026-09-25 | 76 | $35.72 | $2,715 |
| 2026-09-24 | 2,071 | $36.73 | $76,068 |
| 2026-09-22 | 6,925 | $37.97 | $262,942 |
| 2026-09-21 | 10,521 | $41.19 | $433,360 |
| 2026-09-17 | 2,841 | $40.97 | $116,396 |
| 2026-09-16 | 2,359 | $40.11 | $94,619 |
| 2026-09-15 | 1,542 | $40.47 | $62,405 |
| 2026-09-09 | 1,366 | $44.57 | $60,883 |
| 2026-09-08 | 639 | $44.41 | $28,378 |
| 2026-09-03 | 6,117 | $44.70 | $273,430 |
| 2026-09-02 | 177 | $44.02 | $7,792 |
| 2026-08-27 | 25,800 | $49.19 | $1,269,102 |
| 2026-08-25 | 593 | $46.67 | $27,675 |
Showing 1–27 of 27 settlements
Key facts
CIK
2114044
CUSIP
423494103
13F (30d)
89 filings
88 filers
Visit website
Investor relations